| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.061 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.061 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.056 | 0.8 |